Gabapentin Capsule
Product Images NDC 71610-166

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 400 mg (71610 0166 60)

This is a product description for 90 capsules of Gabapentin, USP at a strength of 400mg. The product has a NOC# of 71610016560.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Gabapentin Capsules Fig01)

This is a graph showing the mean pain score over an 8-week study period. The first four weeks were a dose titration period, followed by a four-week fixed dose period. The graph compares the mean pain scores of a group taking a placebo and a group taking 3600 mg/day of Gabapentin. The x-axis shows the weeks of the study, and the y-axis represents the mean pain score.*

FDA Label Image

Figure 2 (Gabapentin Capsules Fig02)

FDA Label Image

Figure 3 (Gabapentin Capsules Fig03)

The text shows a chart with percentage levels from 0% to 100% and a figure numbered as Figure 3. There are two studies mentioned: Study 1 and Study 2. The chart illustrates the proportion of responders with pain reduction (more than 50%) at the Endpoint in Controlled PHN Studies. The chart has percentages displayed along with two p-values: p <0.01 and p< 0.001. The text also mentions two monetary figures in GBP, 3600, and the combination of 1800 and 2400.*

FDA Label Image

Figure 4 (Gabapentin Capsules Fig04)

FDA Label Image

Formula (Gabapentin Capsules Formula)

This appears to be a formula for calculating CLCr, which stands for "Creatinine Clearance" - a measure of kidney function. It involves subtracting the person's age in years from 140, then multiplying that number by their weight in kilograms. This result is then multiplied by their serum creatinine level in milligrams per deciliter (mg/dL) and divided by 72. For female patients, the result is multiplied by 0.85.*

FDA Label Image

Structural Formula (Gabapentin Capsules Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.